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Aim To develop a method for measuring protein carbo-
nylation in human plasma and serum samples, which was 
previously implied in numerous age-related phenotypes.
Methods Protein expression and carbonylation were ana-
lyzed in plasma samples obtained from 12 healthy human 
individuals by using a novel method that combines affin-
ity-based albumin and immunoglobulin G removal, and 
aminooxy dyeing in one- or two-dimensional gels. In addi-
tion, carbonylome profile of plasma and serum was com-
pared. Coefficients of variation and intra-class correlation 
coefficients were used in statistical analysis.
Results Following a step-wise laboratory development 
and optimization process, we measured the protein ex-
pression and carbonylation for 813 proteins from the plas-
ma. The analysis of repeated measurements suggested 
excellent coefficients of variation, which rarely exceeded 
10%. The average value of intra-class correlation based 
on absolute agreement (ICC) for protein expression was 
0.97 ± 0.02, while for carbonylation it was 0.73 ± 0.24. The 
removal of the most extreme protein outlier in carbonyla-
tion assessment increased the average ICC to 0.87 ± 0.04. 
Low protein spot volume substantially reduced repeatabil-
ity. Serum carbonylation estimates were similar to those 
from plasma, with the ICC in the range of 0.86-0.89.
Conclusion We developed a reliable method for the mea-
surement of human plasma protein carbonylation, which 
can be used for the assessment of carbonylome biomark-
ers of aging.
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Protein oxidation was systematically shown to change 
across age and age-related diseases, including Alzheim-
er’s disease, Huntington’s disease, amyotrophic lateral 
sclerosis, and various cancers (1,2). As organism ages, its 
molecules accumulate oxidative damage from reactive 
co-products of respiration and other metabolic process-
es. Although oxidation occurs in all biomolecules, pro-
teins seem to be the most attractive research target due 
to their key role in biological processes. A very interesting 
form of oxidation is carbonylation (3), in which side chains 
of lysine, arginine, proline, and threonine are oxidized (4). 
It is an irreversible oxidative damage, which often leads to 
a loss of protein function and is supposed to be prevalent 
in severe oxidative damage and disease-related protein 
dysfunction (5). Despite rather high interest and favorable 
theoretical background, the measurement of carbonyla-
tion is plagued by numerous methodological problems, 
including the selection of labeling agents, samples, proto-
col, and low repeatability (6,7).
Two important methods substantially improved this field 
of research. The first is the use of fluorescence component 
(8-11), including CyDye fluor dyes (Cy2, Cy3, and Cy5). Be-
sides having the same size and charge, they are pH insensi-
tive, spectrally resolvable, highly sensitive, and bright and 
rather photo-stable, and most importantly, they do not 
affect the mass spectrometry results (12). The second im-
portant method was the development of difference gel 
electrophoresis (DIGE), which quantifies each protein as 
a single spot, reduces gel-gel variability via concomitant 
analysis of multiple samples (13), and yields much better 
repeatability (14,15).
Blood plasma, due to its accessibility, is one of the most 
common sources of information in clinical medicine. It 
is also one of the most diverse sources of protein, which 
contains blood proteins, as well as proteins secreted from 
other tissues (16). At the same time, it is a very complex 
mixture, and diversity and possibility for protein aggre-
gation may present methodological problems in quan-
tification (17,18). Nevertheless, the search for previously 
published articles did not suggest the existing method of 
measuring carbonylation from plasma and serum samples 
using DIGE.
The aim of this study was to develop a reliable method for 
measuring carbonylation from human plasma and serum 
samples, with a focus on the development of a robust 




The participants were selected from the project 10 001 Dal-
matians (19-22) or the research program BioWine (23). In 
order to be considered for enrollment, the participants had 
to be healthy (no history of chronic disease or medication). 
Additionally they underwent a series of clinically relevant 
measurements to confirm their health status. This included 
a complete blood count and basic set of biochemical mea-
surements, ECG, spirometry, blood pressure measurement, 
blood vessel Doppler analysis (ankle-brachial pressure in-
dex), and central arterial pressure and augmentation index 
measurement by Sphygmocor (AtCor Medical, West Ryde, 
Australia). All participants signed the informed consent be-
fore they entered the study, and the study was approved 
by the Ethics Committee of the Medical School, University 
of Split (003-08/13-03/0003 and 003-08/11-03/0005).
Plasma and serum specimens
The study focused on plasma samples, which were ob-
tained from peripheral venous blood samples collected 
in fasting conditions with the Sarstedt EDTA tube (10 mL 
Monovette, Sarstedt, Newton, NC, USA). The same pro-
vider was also used in the case of the serum samples (10 
mL Monovette). The samples were centrifuged at 4°C for 
10 min at 2000 g. The supernatants were centrifuged for 
the second time, and the isolated plasma was immediately 
transferred into a clean tube in aliquots (200-500 μL). Im-
mediately upon collection and separation, all serum and 
plasma aliquots were frozen at -80°C to allow for the sin-
gle-batch analysis of the entire set.
excessive protein removal
In order to deplete highly abundant proteins, mostly al-
bumin and immunoglobulin G (IgG), we used a multiple 
affinity removal column HSA/IgG, 4.6 × 50 mm (Agilent 
Technologies, Santa Clara, CA, USA). An aliquot of 100 μL 
of plasma was diluted with 300 μL of manufacturer’s buffer 
A (Agilent Technologies), containing protease inhibitor mix 
to a final volume of 400 μL and filtered through 0.22 μm 
spin-X centrifuge tube filter (Costar, Washington, DC, USA) 
for 1 min at 16 000 g. The manufacturer’s instructions were 
followed for system and column conditioning, and 100 μL 
of sample was injected at a flow rate of 0.25 mL/min of 
buffer A. Flow-through fraction from 1.25 to 9 min (λ = 280 
nm), containing low abundant proteins, was collected and 
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buffer exchange was performed using Amicon Ultra cen-
trifugal filter devices with 3 kDa cut-off (Merck Millipore, 
Burlington, MS, USA).
The first step of buffer exchange was performed in 4 mL 
Amicon Ultra centrifugal filter devices, where approxi-
mately 2 mL of collected flow-through fraction PBS buffer 
(1X PBS + PI) were added to a final volume of 4 mL. Cen-
trifugation was performed on 4°C for 40 min at 4000 g, af-
ter which a sample was collected and placed to a 0.5 mL 
Amicon Ultra centrifugal devices with 3 kDa cut-off. PBS 
buffer was added to a total volume of 500 μL and centri-
fuged at 4°C for 30 min at 14 000 g. This step was repeated 
3 times, after which a concentrated sample was collected 
and stored at -80°C until further analysis.
Carbonyls labeling
Stock solution of 5 mM CF®647DI-aminooxy dye (CF, Bi-
otium, Fremont, CA, USA) was prepared by adding 322.2 
μL of DMSO to 1 mg of dye (Sigma, St. Louis, MO, USA). 
Sample concentration was measured by using Bradford 
reagent (Sigma), and the appropriate amount of sample 
was diluted with 1X PBS buffer. The first optimization step 
was to adjust the necessary amount of dye for carbonyl 
labeling. A 50-μmolar equivalent of CF aminooxy dye was 
added to the prepared sample as a control sample for la-
beling amount adjustment. To other samples we added 
95%, 80%, 50%, 20%, 10%, 5%, and 1% of CF aminooxy 
dye volume added to control sample. The ligation was ini-
tiated by adding 1/10 volume of aniline acetate catalyst. 
The samples were stained overnight at 4°C and 600 rpm 
to ensure the labeling of all aldehydes and ketones. The 
samples were applied on the SDS-PAGE, which consisted 
of 12.5% resolving and 5% stacking gel. Electrophoresis 
was carried out at 75 V for 30 min, after which the cur-
rent was increased to 150 V. The gels were scanned with 
a Typhoon Scanner (GE Healthcare, Chicago, IL, USA), and 
images were processed with TotalLab Quant (version 13.2, 
TotalLab, Saint Helens, UK).
Selection of the SDS-PAGe percentage
To optimize the percentage of SDS-PAGE, 10%, 12.5%, and 
15% resolving gel was prepared with 5% stacking gel. Be-
fore loading plasma biological replicates on the gels, 4x 
Laemmli SDS electrophoresis buffer (8% SDS, 4% 2-mer-
captoethanol, 35% glycerol, 80% BPB, 150 mM Tris HCl pH 
6.8) was added to the samples. Electrophoresis was carried 
out at 75 V for 30 min, after which the current was increased 
to 150 V. To determine total protein expression, gels were 
stained with Serva purple dye. The first step was to fix the 
gels in 25-50 mL of fixation solution (1% citric acid, 15% 
ethanol) for 15 min with gentle rocking. After this, the gels 
were placed into the staining solution with Serva purple, 
which was prepared fresh (1 V of Serva purple in 250 V 
of staining solution: 0.1 M boric acid, 0.1 M NaOH; Serva, 
Heidelberg, Germany) with gentle rocking for 10 min. The 
gels were then washed in the washing solution (15% eth-
anol) with gentle rocking for 10 min and finally acidified 
with gentle rocking for 10 min in fixation solution. The gels 
were scanned with a Typhoon Scanner, and images were 
processed with TotalLab Quant (version 13.2, TotalLab).
2D electrophoresis
We used labeling CF aminooxy and Cy3 dyes (Lumiprobe, 
Hannover, Germany), once containing 1X PBS buffer and 
once containing UTC buffer (7 M urea, 2 M thiourea, 2% 
CHAPS, 40 mM DTT, 0.5% IPG buffer). After labeling the 
carbonyls and before the labeling with Cy3, the pH of the 
samples was adjusted to 8.5. Internal standard labeled with 
Cy2 (in 1X PBS or UTC) was added to the sample labeled 
with CF aminooxy dye and Cy3. Rehydration buffer A (7M 
urea, 2M thiourea, 2% CHAPS, 60mM DTT, 0.5% IPG buffer, 
0.002% BPB) was added to the pooled sample to a total 
volume per strip of 450 μL and placed into an IPGbox (GE 
health care). IPG strips pH 4-7 length 24 cm (GE Healthcare) 
were carefully placed with gel facing down, and the liquid 
was distributed evenly under the strip. The IPGbox lid was 
closed, and IPG strips were left to rehydrate at room tem-
perature overnight.
The first dimension, isoelectric focusing, was carried out 
in Ettan IPGphor 3 isoelectric focusing system (GE Health-
care). The second dimension was carried out in the Ettan 
DALTsix electrophoresis system (GE Healthcare). IPG strips 
were placed at the top of a 10% SDS-PAGE gel and overlaid 
with agarose sealing solution (25 mM Tris base, 192 mM 
glycine, 0.1% SDS, 0.5% agarose, 0.002% BPB). The electro-
phoresis was performed at 25°C in two steps: at 10 mA/
gel for 1 h and at 12mA/gel until the moment the track-
ing dye leaked out from the gels. Gels were scanned with 
a Typhoon Scanner, and the images were analyzed with 
SameSpots software (TotalLab). Finally, rehydration was 
achieved by the rehydration buffer B (7M Urea, 2M Thio-
urea, 4% CHAPS, 40mM DTT, 1% IPG buffer, 0.002% BPB; 
Agilent Technologies). The summarized scheme of the 
original and modified protocol is provided in the Sup-
plementary Table 1.
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Statistical analysis
The analytic part of this study was based on the repeat-
ability analysis, which was performed with three methods. 
First, we calculated the coefficients of variation (CoV) or 
relative standard deviation, defined as the ratio of standard 
deviation and mean for any set of repeated measurements. 
After CoV calculation for every protein spot, we averaged 
all values to get an average individual CoV. Second, we cal-
culated intra-class correlation coefficients (ICC), based on 
the two-way random, means-focused, absolute agreement 
approach, which focuses on reliability analysis (24). In order 
for our results to be comparable with similar studies, we 
also provided Cronbach’s α estimates. Plasma and serum 
samples were compared by using Bland-Altman analysis, 
as they are two different biological samples from the same 
participant. The coefficients of variability and protein spot 
volume were correlated by using Spearman’s rank correla-
tion test. The protein spots that were in disagreement in 
plasma and serum were analyzed by using t test. The data 
were analyzed in SPSS, version 21 (IBM, Armonk, NY, USA), 
with the level of significance set at P < 0.05. The entire raw 
data set is provided in the Supplementary Material.
ReSultS
Measurement method optimization
During the protocol development, we examined how 
changes in critical steps affected the results. First, we de-
fined the minimum amount of aminooxy in order to 
achieve the least cost and least possible processing con-
tamination. The use of only 20% of the amount suggest-
ed by the manufacturer resulted in a successful labeling of 
98% of all carbonyls, and the use of 10% resulted in 87% of 
labeled carbonyls. For one-dimensional gels we used 0.2 μL 
of CF®647DI aminooxy to 15 μg of proteins (corresponding 
to 13% of the suggested amount) and for two-dimensional 
gels we used 70 μg of proteins (corresponding to 17% of 
the suggested amount), suggesting a possible substantial 
tABle 1. Coefficients of variation (CoV) and intra-class correlation coefficients (ICC; two-way mixed, consistency measure) and Cron-
bach’s alpha for protein expression and carbonylation in 12 analyzed participants
Protein expression
Protein carbonylation
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reduction in comparison with the original protocol (Sup-
plementary Figure 1).
We also aimed to examine how resolving gel on SDS-PAGE 
affected the results. We used 10%, 12.5%, and 15% of re-
solving gel, with the best results obtained in 12.5% resolv-
ing gel with 5% stacking gel (Supplementary Figure 2). 
Another step included the use of the optimal buffer with 
aminooxy dye. The PBS buffer was better than UTC for Cy3 
dye (Supplementary Figure 3). PBS buffer outperformed 
UTC even in the case of aminooxy; 868 distinct protein 
spots were observed in PBS buffer, compared with 779 
spots in UTC buffer (Supplementary Figure 4).
The adherence to the suggested IEF protocol did not yield 
any usable results (possibly due to the existence of natu-
rally occurring NaCl in plasma). Therefore, we performed 
numerous mini-modifications in order to get a meaning-
ful output. This resulted in the use of modified rehydration 
buffer and some deviations from the IEF protocol, main-
ly in electrophoresis duration, voltage, and type (Supple-
mentary Table 1).
Method repeatability analysis
The measurements of plasma samples of 12 healthy par-
ticipants yielded 813 detectable protein expression and 
carbonylation spots. The repeatability of protein expres-
sion data was excellent, with CoV that usually did not ex-
ceed 10% (Table 1). The CoV for carbonylation were slightly 
higher (Table 1), which can be explained by the depen-
dency of protein carbonylation to protein amount and 
subsequent additivity of variability. After the analysis of the 
least repeatable protein spots, we observed a substantial 
outlier. When we removed this spot (protein spot 355), the 
ICC increased (Table 1).
The most obvious cause for lower repeatability of some 
protein spots was the spot volume, which reflects the total 
amount of protein in each spot (r = -0.846; P < 0.001). The 
average value of CoV steadily decreased with the increase 
in spot volume (Supplementary Table 2).
The comparison of plasma and serum results for three par-
ticipants provided reasonably reliable estimates, with CoV 
that varied from 5.05 to 5.82 and ICC that varied from 0.863 
to 0.893. The Bland-Altman analysis suggested 22 outliers 
that were out of limits of agreement (Supplementary Fig-
ures 5-7). The disagreement between plasma and serum 
was not associated with protein spot volume (P = 0.376).
DISCuSSIOn
This study describes a protocol for measurement of plas-
ma protein carbonylation, which was shown to have very 
good repeatability, slightly lower than protein expression. 
Good repeatability is not novel for DIGE (14), but we did 
not find a previous study that investigated the repeatabil-
ity of carbonylation measurement. As expected, variation 
was higher when the abundance of protein was very low, 
ie, too close to the detection limit, affecting protein carbo-
nylation even more due to its dependency on expression. 
Although this is not the first attempt to measure carbo-
nylated protein from human plasma (25,26), our method 
provides a wider protein coverage and more repeatable 
results.
The protein spot volume was the main factor that defined 
the repeatability of carbonylation estimates. While this 
finding is intuitive, the disagreement in plasma vs serum 
was seemingly different, and did not depend on this. This 
indicates that the disagreement is more likely due to dif-
ferent protein composition between plasma and serum. A 
definitive answer can be provided by the identification of 
the proteins. Nevertheless, this study shows that plasma 
and serum can be used more or less interchangeably in 
carbonylation assessment.
One of the main limitations of the proposed method is that 
it is only able to quantify the carbonylation signal, with-
out having the ability to identify the protein in the spot. 
This step is usually performed in the mass spectrometry 
or a similar method for identification. This is the main rea-
son why we referred to the results as spots, since we were 
not able to identify these spots. Therefore, the next stage 
of the method development is to integrate it with one of 
such methods, in order to facilitate its biological validation 
and further progression toward a possible biomarker dis-
covery.
A growing number of methods and approaches that as-
sess biomarkers of aging are being tested. The multidi-
mensionality of aging and its nonlinear nature (27) will 
surely require the refinement of multi-molecular biomark-
ers, which will reflect different (patho-)biological processes 
across different stages of life. In addition, the use of mul-
tiple biomarker types will enable the analysis of their pos-
sible synergy or understanding of shared variance, which 
can further contribute to our understanding of aging but 
also improve the predictive value of biomarkers. This is 
where the existing long-term cohort biobanks are 
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coming into the focus of science of aging (28), since they 
offer a quick and easily accessible source of life-long data.
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